Molex Expands Offerings for Medical Markets With Investment in Vasa Applied Technologies
12 Septiembre 2013 - 8:10AM
Business Wire
Molex Incorporated (NASDAQ: MOLX) (NASDAQ: MOLXA), a global
electronics components company, announced today it has signed
definitive agreements as a strategic partner and investor in Vasa
Applied Technologies Ltd., based in Or Yehuda, Israel. Vasa is a
start-up that has developed an innovative, patent-pending
technology that allows accurate measurements of fluid flow rates
and initial designs will be targeting medical applications.
“This partnership with Vasa is a great fit for Molex because it
expands our ability to provide medical device and sensor
solutions,” said Tim Ruff, senior vice president of business
development and corporate strategy, Molex. “Vasa has developed a
unique product that addresses urgent clinical needs. We expect this
technology to have many more applications beyond medical markets
when combined with Molex’s engineering talents.”
“We are very excited to join forces with Molex,“ said Jacob
Polger, Vasa’s co-founder and chief executive officer. “With
Molex’s global sales force and engineering capabilities, we expect
to significantly increase our technology reach in new geographies
and markets.”
About Molex Incorporated
Providing more than connectors, Molex delivers complete
interconnect solutions for a number of markets including: data
communications, telecommunications, consumer electronics,
industrial, automotive, commercial vehicle, aerospace and defense,
medical and lighting. Established in 1938, the company operates 41
manufacturing locations in 15 countries. The Molex website is
www.molex.com. Follow us at www.twitter.com/molexconnectors, watch
our videos at www.youtube.com/molexconnectors, connect with us at
www.facebook.com/molexconnectors and read our blog at
www.connector.com.
About Vasa Applied Technologies Ltd.
Vasa Applied Technologies Ltd. was established in 2009. It is an
Israeli start-up company that has developed an innovative,
patent-pending technology that allows accurate measurements of
pulsating, low flow rates.
Forward-Looking
Statements
Statements in this release that are not historical are
forward-looking and are subject to various risks and uncertainties
that could cause actual results to vary materially from those
stated. Words such as “expect,” “anticipate,” “outlook,”
“forecast,” “could,” “project,” “intend,” “plan,” “continue,”
“believe,” “seek,” “estimate,” “should,” “may,” “assume,”
“potential,” variations of such words and similar expressions are
intended to identify such forward-looking statements.
Forward-looking statements are based on currently available
information and include, among others, the discussion under
“Outlook.” These statements are not guarantees of future
performance and involve certain risks, uncertainties and
assumptions that are difficult to predict. Respective risks,
uncertainties, and assumptions that could affect the outcome or
results of operations are described in Part 1, Item 1A of our
Annual Report on Form 10-K for the year ended June 30, 2012 and the
Form 10-Q for the quarters ended September 30, 2012, December 31,
2012 and March 31, 2013, which are incorporated by reference and in
other reports that Molex files or furnishes with the Securities and
Exchange Commission.
We have based our forward-looking statements on our management’s
beliefs and assumptions based on information available to
management at the time the statements are made. We caution you that
actual outcomes and results may differ materially from what is
expressed, implied, or forecast by our forward-looking statements.
Reference is made in particular to forward-looking statements
regarding growth strategies, industry trends, global economic
conditions, success of customers, cost of raw materials, value of
inventory, currency exchange rates, labor costs, protection of
intellectual property, cost reduction initiatives, acquisition
synergies, manufacturing strategies, product development
introduction and sales, regulatory changes, competitive strengths,
natural disasters, unauthorized access to data, government
investigations and outcomes of legal proceedings. Except as
required under the federal securities laws, we do not have any
intention or obligation to update publicly any forward-looking
statements after the distribution of this report, whether as a
result of new information, future events, changes in assumptions,
or otherwise.
Molex IncorporatedSteve Martens, 630-527-4344 (Investors)Vice
President, Investor Relationssteve.martens@molex.comSusan Armitage,
630-527-4561 (Editors)Vice President, Corporate
Communicationssusan.armitage@molex.com
Molex Incorporated - Class A (MM) (NASDAQ:MOLXA)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Molex Incorporated - Class A (MM) (NASDAQ:MOLXA)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024